Radiographically identified necrosis after 90Y microsphere brachytherapy: a new standard for oncologic response assessment?
Welsh
James S
JS
Department of Human Oncology, University of Wisconsin-Madison, UW Cancer Center-Riverview, 410 Dewey St., Wisconsin Rapids, WI 54494, USA. welsh@humonc.wisc.edu
D001918:Brachytherapy / Q000379:methods; D006528:Carcinoma, Hepatocellular / Q000000981:diagnostic imaging* / Q000401:mortality / Q000532:radiotherapy*; D006801:Humans; D008113:Liver Neoplasms / Q000000981:diagnostic imaging* / Q000401:mortality / Q000532:radiotherapy*; D009336:Necrosis / Q000000981:diagnostic imaging; D009687:Nuclear Proteins; D016601:RNA-Binding Proteins; D011857:Radiographic Image Interpretation, Computer-Assisted / Q000379:methods; D012015:Reference Standards; D015203:Reproducibility of Results; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D012680:Sensitivity and Specificity; D014057:Tomography, X-Ray Computed / Q000379:methods*; D016896:Treatment Outcome; D015021:Yttrium Radioisotopes / Q000627:therapeutic use*
C113292:MCRS1 protein, human; D009687:Nuclear Proteins; D016601:RNA-Binding Proteins; D015021:Yttrium Radioisotopes